← Back to screener

Orthofix Medical Inc. OFIX

Rank #1845 · Nasdaq · $0.4B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
40.8
P/E
-2.4
P/B
1.09
ROE
-44.9%
Op. Margin
-18.6%
Debt Ratio
116%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E -2.4x, P/B 1.09x. Ranks in the top 55% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -44.9%. Ranks in the top 84% of the universe.

Safety ★★★☆☆
Average

Debt ratio 116%. Ranks in the top 45% of the universe.

Growth ★★★★★
Excellent

Revenue growth of 62.1% year over year. Ranks in the top 6% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.1B$-0.0B$0.2B–150
2012–$0.1B$0.0B$0.3B–124
2013–$0.0B$-0.0B$0.3B–131
2014–$0.1B$0.0B$0.4B–29
2015–$-0.0B$-0.0B$0.4B–26
2016–$0.0B$-0.0B$0.3B–37
2017–$0.0B$-0.0B$0.3B–36
2018$0.4B$0.0B$0.0B$0.3B5.137
2019$0.4B$0.0B$0.0B$0.3B9.450
2020$0.5B$0.0B$0.0B$0.3B6.657
2021$0.5B$-0.0B$-0.0B$0.3B-4.150
2022$0.4B$-0.0B$0.0B$0.3B-1.543
2023$0.5B$-0.0B$-0.0B$0.4B-1.834
2024$0.5B$-0.0B$-0.0B$0.3B-2.997
2025$0.7B$-0.1B$-0.2B$0.3B-18.6116

← See the full screener